Literature DB >> 22037380

Risk of breast cancer in families with cleft lip and palate.

Alexander Dietz1, Dorthe Almind Pedersen, Rune Jacobsen, George L Wehby, Jeffrey C Murray, Kaare Christensen.   

Abstract

PURPOSE: To test whether female subjects in families with cleft lip and/or palate (CL/P) have an increased risk of breast cancer.
METHODS: By using the Danish Facial Cleft Registry, we identified female subjects with CL/P, mothers of children with CL/P, and sisters to CL/P cases for the Danish birth cohorts 1911-1975. These subjects were compared with a 5% random sample of these cohorts regarding the incidence and age of onset for breast cancer registered in the Danish Hospital Discharge Register 1977-2005.
RESULTS: Examining 48,404 person-years for 1809 female CL/P cases (49 breast cancer cases) and 212,795 person-years for 7935 female relatives (188 breast cancer cases), we found no increased breast cancer risk for either CL/P cases (hazard ratio [HR], 1.23; 95% confidence interval (CI), 0.92-1.63), mothers of children with CL/P (HR, 0.93; 95% CI, 0.80-1.08), or sisters of CL/P cases (HR, 0.94; 95% CI, 0.55-1.60), nor was there any significant differences in age of onset.
CONCLUSION: Both epidemiological and genetic studies have suggested common etiological factors for breast cancer and CL/P. However, in this population-based study we were not able to confirm a general increase in the risk of breast cancer among female subjects in families with CL/P.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22037380      PMCID: PMC3237814          DOI: 10.1016/j.annepidem.2011.09.003

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  54 in total

Review 1.  Unraveling human cleft lip and palate research.

Authors:  A R Vieira
Journal:  J Dent Res       Date:  2008-02       Impact factor: 6.116

2.  MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients.

Authors:  Ev Stralen; R J Leguit; H Begthel; L Michaux; A Buijs; H Lemmens; J M Scheiff; C Doyen; P Pierre; F Forget; H C Clevers; Bjeg Bast
Journal:  Leukemia       Date:  2008-10-02       Impact factor: 11.528

3.  Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation.

Authors:  K Osoegawa; G M Vessere; K H Utami; M A Mansilla; M K Johnson; B M Riley; J L'Heureux; R Pfundt; J Staaf; W A van der Vliet; A C Lidral; E F P M Schoenmakers; A Borg; B C Schutte; E J Lammer; J C Murray; P J de Jong
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

4.  Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.

Authors:  Jie Liang; Peizhan Chen; Zhibin Hu; Xiaoyi Zhou; Lu Chen; Mian Li; Yan Wang; Jinhai Tang; Hui Wang; Hongbing Shen
Journal:  Carcinogenesis       Date:  2008-10-08       Impact factor: 4.944

5.  AXIS inhibition protein 2, orofacial clefts and a family history of cancer.

Authors:  Renato Menezes; Mary Louise Marazita; Toby Goldstein McHenry; Margaret E Cooper; Kathleen Bardi; Carla Brandon; Ariadne Letra; Rick A Martin; Alexandre Rezende Vieira
Journal:  J Am Dent Assoc       Date:  2009-01       Impact factor: 3.634

Review 6.  Acute leukemias in children with Down syndrome.

Authors:  Michel C Zwaan; Dirk Reinhardt; Johann Hitzler; Paresh Vyas
Journal:  Pediatr Clin North Am       Date:  2008-02       Impact factor: 3.278

7.  Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.

Authors:  Timothy R Rebbeck; Angela DeMichele; Teo V Tran; Saarene Panossian; Greta R Bunin; Andrea B Troxel; Brian L Strom
Journal:  Carcinogenesis       Date:  2008-11-20       Impact factor: 4.944

8.  Integrated profiling of basal and luminal breast cancers.

Authors:  José Adélaïde; Pascal Finetti; Ismahane Bekhouche; Laetitia Repellini; Jeannine Geneix; Fabrice Sircoulomb; Emmanuelle Charafe-Jauffret; Nathalie Cervera; Jérôme Desplans; Daniel Parzy; Eric Schoenmakers; Patrice Viens; Jocelyne Jacquemier; Daniel Birnbaum; François Bertucci; Max Chaffanet
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

9.  Familial risk of oral clefts by morphological type and severity: population based cohort study of first degree relatives.

Authors:  Ase Sivertsen; Allen J Wilcox; Rolv Skjaerven; Hallvard Andreas Vindenes; Frank Abyholm; Emily Harville; Rolv Terje Lie
Journal:  BMJ       Date:  2008-02-04

10.  Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip.

Authors:  Fedik Rahimov; Mary L Marazita; Axel Visel; Margaret E Cooper; Michael J Hitchler; Michele Rubini; Frederick E Domann; Manika Govil; Kaare Christensen; Camille Bille; Mads Melbye; Astanand Jugessur; Rolv T Lie; Allen J Wilcox; David R Fitzpatrick; Eric D Green; Peter A Mossey; Julian Little; Regine P Steegers-Theunissen; Len A Pennacchio; Brian C Schutte; Jeffrey C Murray
Journal:  Nat Genet       Date:  2008-10-05       Impact factor: 38.330

View more
  10 in total

Review 1.  Genetics of cleft lip and cleft palate.

Authors:  Elizabeth J Leslie; Mary L Marazita
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

2.  Long-term effects of oral clefts on health care utilization: a sibling comparison.

Authors:  Morten Saaby Pedersen; George L Wehby; Dorthe Almind Pedersen; Kaare Christensen
Journal:  Eur J Health Econ       Date:  2014-06-08

Review 3.  The evolution of human genetic studies of cleft lip and cleft palate.

Authors:  Mary L Marazita
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-06-06       Impact factor: 8.929

4.  BRCA1 and BRCA2 gene variants and nonsyndromic cleft lip/palate.

Authors:  Nicholas Rodriguez; Lorena Maili; Brett T Chiquet; Susan H Blanton; Jacqueline T Hecht; Ariadne Letra
Journal:  Birth Defects Res       Date:  2018-06-19       Impact factor: 2.344

5.  The effects of oral clefts on hospital use throughout the lifespan.

Authors:  George L Wehby; Dorthe Almind Pedersen; Jeffrey C Murray; Kaare Christensen
Journal:  BMC Health Serv Res       Date:  2012-03-09       Impact factor: 2.655

6.  Genome-wide association studies in dogs and humans identify ADAMTS20 as a risk variant for cleft lip and palate.

Authors:  Zena T Wolf; Harrison A Brand; John R Shaffer; Elizabeth J Leslie; Boaz Arzi; Cali E Willet; Timothy C Cox; Toby McHenry; Nicole Narayan; Eleanor Feingold; Xioajing Wang; Saundra Sliskovic; Nili Karmi; Noa Safra; Carla Sanchez; Frederic W B Deleyiannis; Jeffrey C Murray; Claire M Wade; Mary L Marazita; Danika L Bannasch
Journal:  PLoS Genet       Date:  2015-03-23       Impact factor: 5.917

7.  Nonsyndromic cleft lip and palate, gastric cancer and tooth agenesis.

Authors:  E-F Cardoso; D-R-B Martelli; R-A Machado; R-D Coletta; J-D de Souza; F-T Barbosa; M-F-L de Figueiredo; L-G-V Coelho; H Martelli-Júnior
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-01-01

8.  FAT4 identified as a potential modifier of orofacial cleft laterality.

Authors:  Sarah W Curtis; Daniel Chang; Miranda R Sun; Michael P Epstein; Jeffrey C Murray; Eleanor Feingold; Terri H Beaty; Seth M Weinberg; Mary L Marazita; Robert J Lipinski; Jenna C Carlson; Elizabeth J Leslie
Journal:  Genet Epidemiol       Date:  2021-06-15       Impact factor: 2.135

9.  An integrative, genomic, transcriptomic and network-assisted study to identify genes associated with human cleft lip with or without cleft palate.

Authors:  Fangfang Yan; Yulin Dai; Junichi Iwata; Zhongming Zhao; Peilin Jia
Journal:  BMC Med Genomics       Date:  2020-04-03       Impact factor: 3.063

Review 10.  Assessment of candidate genes and genetic heterogeneity in human non syndromic orofacial clefts specifically non syndromic cleft lip with or without palate.

Authors:  Komal Saleem; Tahir Zaib; Wenjing Sun; Songbin Fu
Journal:  Heliyon       Date:  2019-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.